The Open Choice: Researchers Who Walked Away From Prestige Publishing—And Lived to Tell About It

The academic job market is not known for rewarding idealism. Tenure clocks run short, grant panels are conservative, and the unwritten rules governing which publications "count" are enforced with surprising consistency across disciplines and institutions. Against this backdrop, a researcher who deliberately chooses open access publication over a prestigious paywalled journal is making a bet that the system will eventually catch up with its stated values.

Some of those bets are paying off. Others are still pending. And a few have cost researchers more than they anticipated. The following profiles—drawn from interviews and publicly available accounts—document the experiences of scholars who made the open choice at different career stages, in different fields, and with strikingly different outcomes.

The Graduate Student Who Went Open From Day One

When Maya Chen finished her doctoral dissertation in computational linguistics at a large public university in the Midwest, she had two papers ready to submit. Her advisor strongly encouraged submission to a pair of well-regarded subscription journals in her field. Chen submitted to both—and then, after acceptance, exercised her author rights to post preprint versions to the arXiv repository before publication.

The journals permitted this under their standard author agreements, but the department's culture did not entirely approve. During her job search, one hiring committee chair mentioned in feedback that her publication record looked "informal" compared to candidates who had published in the same journals without the accompanying preprints. She was not offered that position.

She was, however, offered two others—both at institutions where faculty had signed DORA and actively discussed open access in their departmental culture. "The preprints had been downloaded thousands of times before the journal versions even appeared," she said. "At the schools that cared about that, it was a real advantage. At the ones that only looked at the journal name, it wasn't."

Her experience illustrates a bifurcation that is quietly reshaping academic hiring: institutions that have genuinely internalized open access values are beginning to attract researchers who share them, while more traditional departments continue to filter for prestige-journal credentials.

The Mid-Career Ecologist Who Left a High-Impact Journal Mid-Review

Dr. James Okafor, a conservation biologist at a southeastern research university, had a paper under review at a high-profile subscription journal for eleven months before withdrawing it and submitting to PLOS ONE. The decision was partly pragmatic—he needed the publication for a pending grant renewal—but it was also principled.

"The review process at the original journal was opaque and slow, and I had no reason to believe the delay was making the science better," Okafor said. "Meanwhile, the data were sitting unpublished while policy decisions were being made in the area I was studying."

The grant panel reviewing his renewal was not uniformly supportive. One reviewer's written comments noted that his recent publications were "not in top-tier venues," despite the fact that PLOS ONE maintains rigorous peer review standards and his paper had been downloaded more than 8,000 times in its first year. His renewal was funded, but at a lower level than requested.

Okafor has since published exclusively in open access venues and makes all of his underlying data freely available through his institutional repository. His citation count has grown steadily, and he attributes a collaboration with a research group in Kenya—which reached out after reading one of his freely available papers—to the decision to prioritize access. "That collaboration produced work that wouldn't have happened any other way," he said. "No paywall, no partnership."

The Tenured Professor Who Resigned From a Journal Editorial Board

Not all open access advocacy happens at the submission stage. Dr. Patricia Reyes, a tenured sociologist at a large urban university in the Northeast, spent several years on the editorial board of a well-regarded subscription journal before resigning in 2021 in a public letter that circulated widely on academic social media.

Her letter cited the journal's refusal to adopt even a hybrid open access model, its pricing practices—which she documented had increased by more than 200 percent over a decade—and what she described as a pattern of accepting papers from affiliated institutions at disproportionate rates. "I was lending my credibility to a system I found indefensible," she wrote.

The professional response was mixed. Several colleagues expressed private support while declining to sign a follow-up open letter she circulated. One senior colleague suggested the resignation had been "unnecessarily confrontational." A foundation that had previously funded her research requested a meeting to discuss her "public profile," though the grant was ultimately renewed without conditions.

Reyes now serves on the editorial board of two open access journals and has testified before a congressional subcommittee on research access policy. She describes the resignation as the most professionally consequential decision of her career—and, on balance, the right one. "Tenure exists so that faculty can take positions like this," she said. "If you can't use it for something that matters, what's it for?"

The Biomedical Researcher Who Chose PubMed Central Over The Lancet

In biomedical research, the stakes of publication venue are unusually high. Funding, clinical credibility, and media attention all correlate closely with journal prestige. Dr. Samuel Park, a physician-researcher at a mid-sized academic medical center in the Pacific Northwest, had a paper accepted at The Lancet before withdrawing it over the journal's embargo policies, which would have delayed open access posting by twelve months.

"The research had direct clinical implications," Park explained. "Twelve months is a long time when you're talking about treatment protocols."

He submitted instead to PLOS Medicine, which published the paper with immediate open access. The paper was subsequently cited in clinical guidelines issued by a professional medical association—a form of real-world impact that, he notes, would likely have been slower to materialize had the paper remained paywalled during its initial visibility window.

The professional cost was tangible. A promotion review that year included written feedback noting that his publication record did not reflect "the top journals in the field." He was promoted, but colleagues indicated informally that the committee discussion had been contentious. "I knew the risk going in," Park said. "I'd do it the same way again."

The Common Thread

Across these accounts, several patterns emerge. First, the professional risks of open access publishing are real, unevenly distributed, and most acute at institutions that have adopted open access rhetoric without changing their actual evaluation criteria. Second, the benefits—broader readership, faster policy uptake, unexpected collaborations, and in some cases measurable citation advantages—are also real, and they tend to materialize over longer time horizons than tenure committees typically consider.

Third, and perhaps most importantly, the researchers who describe the most positive outcomes are those who made their choices deliberately, understood the institutional context they were operating in, and found departments or funders who shared their values. Open access publishing is not yet a universally safe career strategy in American academia. But for researchers willing to navigate its risks thoughtfully, it is increasingly a viable one—and for the readers who benefit from freely available scholarship, it is an invaluable one.